Levosimendan for bridging in a pediatric patient with Alström syndrome awaiting heart-lung transplantation.
Hitz
Marc-Phillip
MP
Bertram
Harald
H
Köditz
Harald
H
Görler
Heidi
H
Happel
Christoph M
CM
Wessel
Armin
A
Yelbuz
T Mesud
TM
D000015:Abnormalities, Multiple / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D000293:Adolescent; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D018797:Cell Cycle Proteins; D016041:Heart-Lung Transplantation; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D008297:Male; D011506:Proteins; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan; D013577:Syndrome; D016896:Treatment Outcome; D014850:Waiting Lists
C490729:ALMS1 protein, human; D002316:Cardiotonic Agents; D018797:Cell Cycle Proteins; D006835:Hydrazones; D011506:Proteins; D011724:Pyridazines; D000077464:Simendan